Article View: be.science
Article #336Cancer - Press review (October 29, 2011) – Revue de presse (29 octobre 2011)
From: SciMedWeb
Date: Sat, 29 Oct 2011 10:22
Date: Sat, 29 Oct 2011 10:22
185 lines
9650 bytes
9650 bytes
Cancer – Press Review – Revue de Presse Every week on http://marclacroixcancerblog.blogspot.com Chaque semaine sur http://marclacroixcancerblog.blogspot.com Press review (October 29, 2011) – Revue de presse (29 octobre 2011) Male Breast Cancer: Limited Awareness Costs Lives, New Study Says‎ Men have a breast cancer incidence rate less than 1 percent of that of females, but when they do get the disease, it is often more advanced, according to a sweeping new study. The research, published earlier this month in the Journal of Clinical Oncology, looked at breast cancer in 6 countries over the last 40 years. Researchers found that men had poorer five-year survival rates than women, and the disease generally occurred later in life for them. By Catherine Pearson. In Huffington Post http://www.huffingtonpost.com/2011/10/27/male-breast-cancer-awareness-lives_n_1034927.html Lung cancer screening with X-rays isn't beneficial Routine chest X-rays do not prevent lung cancer deaths, not even in smokers or former smokers, according to a big government study challenging a once common type of screening. In USA Today http://yourlife.usatoday.com/health/medical/cancer/story/2011-10-26/Lung-cancer-screening-with-X-rays-isnt-beneficial/50933380/1 Doctors split on Avastin for breast cancer - survey An international survey of cancer doctors shows that many question U.S. health advisers' 2010 rejection of Roche Holding's drug Avastin to treat advanced breast cancer. By Andrew M. Seaman. Reuters http://www.reuters.com/article/2011/10/27/us-roche-avastin-idUSTRE79Q47T20111027 Double Trouble From HPV Two new studies have come out that highlight significant news around HPV – Human Papillomavirus. HPV is known to increase the risk of cervical cancer in women significantly. Now, a study in the New England Journal of Medicine shows that an HPV vaccine that helps prevent HPV in women, can help prevent most anal cancers in gay men.. By Doc Gurley. In San Francisco Chronicle (blog) http://blog.sfgate.com/gurley/2011/10/27/double-trouble-from-hpv/ Increase in Borderline Ovarian Cancer After IVF Ovarian stimulation by in vitro fertilization (IVF) increases the risk for borderline ovarian tumors, but the risk for invasive ovarian cancer is not significantly increased, a new study concludes. It also found no increase in cancer risk with an increased number of IVF cycles. The study was published online October 26 in Human Reproduction. By Becky McCall. In Medscape http://www.medscape.com/viewarticle/752379 Research makes it possible to predict how cancers will respond to chemo. Finding rewrites old theory of why chemo works Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's tumor cells are already "primed" for death. In a study published online by the journal Science on Oct. 27, the researchers report that cancer cells that are on the verge of self- destruction are more likely to succumb to certain chemotherapy agents than cancer cells that have yet to reach that stage. The discovery suggests that it may be possible to predict which cancer patients are most likely to benefit from chemotherapy, as well as to make chemotherapy drugs more effective by pushing tumor cells closer to the point of suicide. In EurekAlert http://www.eurekalert.org/pub_releases/2011-10/dci-rmi102511.php Mummy Had History's Second-Oldest Prostate Cancer Case‎‎ Some 2,250 years ago in Egypt, a man known today only as M1 struggled with a long, painful, progressive illness. A dull pain throbbed in his lower back, then spread to other parts of his body, making most movements a misery. When M1 finally succumbed to the mysterious ailment between the ages of 51 and 60, his family paid for him to be mummified so that he could be reborn and relish the pleasures of the afterworld. Now an international research team has diagnosed what ailed M1: the oldest known case of prostate cancer in ancient Egypt and the second oldest case in the world By Heather Pringle. In Wired News http://www.wired.com/wiredscience/2011/10/mummy-prostate-cancer/ NHS breast cancer screening to be reviewed England’s breast cancer screening programme could be scaled back amid concerns from scientists that it is leading to women undergoing surgery unnecessarily. By Martin Beckford. In Telegraph.co.uk http://www.telegraph.co.uk/health/healthnews/8848347/NHS-breast-cancer-screening-to-be-reviewed.html Cancer, the growing silent killer among the Ugandan population‎ Having dedicated October as a month to focus on cancer, we have been running stories on various types of the disease focusing on the causes, treatment, statistics and methods of prevention. As we wrap up our series, we look at the state of cancer in the country. Over the years, cancer has become more common with one in 500 people suffering from one type or another, a warning that if you have not yet checked or had screening for those types that can be screened, you should. By Flavia Lanyero. In Daily Monitor http://www.monitor.co.ug/Magazines/Health+++Living/-/689846/1262542/-/mavwmiz/-/ Les bienfaits du café contre le cancer de la peau se confirment La consommation régulière de café réduirait les risques de cancer de la peau, montre une étude américaine. Radio-Canada http://www.radio-canada.ca/nouvelles/science/2011/10/25/001-cafe-cancer-peau.shtml Cancer du poumon: une radiographie annuelle ne réduit pas la mortalité Des radiographies annuelles de la cage thoracique ne réduisent pas la mortalité résultant du cancer du poumon, selon une vaste étude clinique présentée mercredi aux Etats-Unis qui montre l'inutilité de cette procédure. AFP http://www.google.com/hostednews/afp/article/ALeqM5is6uoUR21hPcrzp0mxgkAkJvjBxw?docId=CNG.ca83feaf2a770de47c03ff7c91039ecc.191 Ouverture du premier procès de l'amiante en Belgique‎ Le premier procès de victimes belges de l'amiante s'est ouvert lundi à Bruxelles, où le groupe belgo-suisse Eternit est accusé par une famille décimée par le cancer d'avoir négligé la nocivité de cette substance utilisée pendant des décennies dans la construction. RTBF http://www.rtbf.be/info/societe/detail_ouverture-du-premier-proces-de-l-amiante-en-belgique?id=6974273 Le vaccin anti-papillomavirus humains préviendrait le cancer anal Le vaccin contre les papillomavirus humains (HPV), transmis sexuellement et responsables de nombreux cancers utérins, s'est avéré efficace pour prévenir des infections et lésions anales pré- cancéreuses chez des hommes homosexuels, selon une étude clinique publiée mercredi. AFP http://www.google.com/hostednews/afp/article/ALeqM5g3VUfLEhfYqPgR9QkC1JnPXAKUTg?docId=CNG.ca83feaf2a770de47c03ff7c91039ecc.291 Les cabines de bronzage favorisent les cancers‎ Ça chauffe pour les cabines de bronzage. Lors du 10e congrès international de l'Association américaine de recherche contre le cancer (AACR) qui vient de s'achever à Boston (États-Unis), les chercheurs ont une nouvelle fois pointé du doigt les méfaits des cabines à UV (rayons ultraviolets responsables du bronzage), les accusant de favoriser la survenue de cancers de la peau : le baso- cellulaire (le plus fréquent), le spino-cellulaire et le mélanome malin. Par Anne Jouan. Dans Le Figaro http://sante.lefigaro.fr/actualite/2011/10/24/14947-cabines-bronzage-favorisent-cancers Cancer Blog – Marc Lacroix – Le Blogue du Cancer http://marclacroixcancerblog.blogspot.com Marc Lacroix – InTextoResearch – Baelen (10/2011)
Technical Details
Message-ID:
<9b023854-f96e-4d0e-8174-103b60035f56@p16g2000yqd.googlegroups.com>Path:
arc1-ca.pugleaf.net!p6ni22324pbn.0!nntp.google.com!news1.google.com!postnews.google.com!p16g2000yqd.googlegroups.com!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: f5500,a9d29e5254df20a4,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.68.35.68 with SMTP id f4mr5816121pbj.5.1319886193213;
Sat, 29 Oct 2011 04:03:13 -0700 (PDT)
Path: arc1-ca.pugleaf.net!p6ni22324pbn.0!nntp.google.com!news1.google.com!postnews.google.com!p16g2000yqd.googlegroups.com!not-for-mail
From: SciMedWeb <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press review (October 29, 2011) – Revue de presse (29 octobre 2011)
Date: Sat, 29 Oct 2011 03:22:14 -0700 (PDT)
Organization: http://groups.google.com
Lines: 185
Message-ID: <9b023854-f96e-4d0e-8174-103b60035f56@p16g2000yqd.googlegroups.com>
NNTP-Posting-Host: 81.247.105.20
Mime-Version: 1.0
X-Trace: posting.google.com 1319886108 1074 127.0.0.1 (29 Oct 2011 11:01:48 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 29 Oct 2011 11:01:48 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: p16g2000yqd.googlegroups.com; posting-host=81.247.105.20; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-Google-Web-Client: true
X-Google-Header-Order: UHALERCNK
X-HTTP-UserAgent: Opera/9.80 (Windows NT 5.1; U; fr) Presto/2.8.131 Version/11.11,gzip(gfe)
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable